EPISODE · Sep 4, 2025 · 9 MIN
Stacy Blain is the Founder and CEO of Concarlo Therapeutics, which is the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance
from Biotech CEO Sisterhood · host BiotechTV
She describes the unmet need for patients who no longer respond to the large CDK4/6 class of medicines, and the decades of work she has put into solving the problem of adding CDK2 inhibition into the equation.
Embed this episode
NOW PLAYING
Stacy Blain is the Founder and CEO of Concarlo Therapeutics, which is the first company to target CDK4/6-driven cell proliferation and CDK2-driven resistance
0:00
9:25
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Biotech CEO Sisterhood?
This episode is 9 minutes long.
When was this Biotech CEO Sisterhood episode published?
This episode was published on September 4, 2025.
Can I download this Biotech CEO Sisterhood episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!